Table 2.
Urate quartiles, μmol/L | Men (N = 508) | Urate quartiles, μmol/L | Women (N = 532) | ||||||
---|---|---|---|---|---|---|---|---|---|
OR, univariable | p value | OR, multivariable | p value | OR, univariable | p value | OR, multivariable | p value | ||
CAC examined (N = 508)a CAC+ (N = 293) |
CAC examined (N = 532)a CAC+ (N = 137) |
||||||||
31–307, ref | 1 | 1 | 143–229, ref | 1 | 1 | ||||
308–346 | 1.6 (1.0–2.7) | 0.049 | 2.2 (1.2–4.0) | 0.008 | 230–262 | 1.0 (0.6–1.8) | 0.97 | 0.8 (0.4–1.6) | 0.5 |
347–391 | 1.6 (0.9–2.5) | 0.08 | 1.9 (1.0–3.6) | 0.04 | 263–304 | 1.1 (0.6–1.9) | 0.8 | 1.0 (0.5–1.9) | 0.9 |
392–584 | 2.0 (1.2–3.4) | 0.007 | 2.3 (1.2–4.4) | 0.01 | 305–702 | 1.5 (0.9–2.6) | 0.2 | 1.0 (0.5–2.0) | 0.96 |
CIMT examined (N = 436)a CIMT+ (N = 106) |
CIMT examined (N = 475)a CIMT+ (N = 117) |
||||||||
31–307, ref | 1 | 1 | 143–229, ref | 1 | 1 | ||||
308–346 | 1.5 (0.8–2.7) | 0.2 | 1.2 (0.6–2.4) | 0.5 | 230–262 | 1.2 (0.6–2.2) | 0.6 | 1.2 (0.6–2.3) | 0.7 |
347–391 | 0.9 (0.5–1.7) | 0.7 | 0.7 (0.3–1.4) | 0.3 | 263–304 | 1.3 (0.7–2.4) | 0.4 | 1.0 (0.5–2.1) | 0.9 |
392–584 | 1.3 (0.7–2.5) | 0.4 | 0.9 (0.4–1.8) | 0.7 | 305–702 | 1.6 (0.9–2.9) | 0.1 | 1.0 (0.5–2.2) | 0.99 |
Carotid plaque examined (N = 507)a Plaque+ (N = 308) |
Carotid plaque examined (N = 526)a Plaque+ (N = 268) |
||||||||
31–307, ref | 1 | 1 | 143–229, ref | 1 | 1 | ||||
308–346 | 1.6 (0.95–2.6) | 0.08 | 1.8 (1.0–3.2) | 0.03 | 230–262 | 0.8 (0.5–1.3) | 0.4 | 0.9 (0.5–1.6) | 0.7 |
347–391 | 1.2 (0.7–1.9) | 0.6 | 1.1 (0.6–2.0) | 0.7 | 263–304 | 1.1 (0.7–1.7) | 0.8 | 1.3 (0.7–2.2) | 0.4 |
392–584 | 1.5 (0.9–2.4) | 0.1 | 1.6 (0.9–2.9) | 0.2 | 305–702 | 0,99 (0.6–1.6) | 0.95 | 1.1 (0.6–2.1) | 0.7 |
aThe total number of subjects, where CAC score, CIMT, and plaque score respectively, were calculated
CAC+: total CAC score > 0
CIMT+: CIMT > 75th percentile
Plaque+: plaque score > 0